- US-listed companies
- Protagonist Therapeutics, Inc
- Balance sheet
Protagonist Therapeutics, Inc【PTGX】Balance sheet
Market cap
$5B
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 21 | 106 | 83 | 33 | 118 | 124 | 126 | 187 | 97 |
| Marketable securities, current | 57 | 38 | 93 | 100 | 188 | 203 | 112 | 155 | 322 |
| Total cash & short-term investments | 78 | 144 | 176 | 133 | 306 | 327 | 238 | 342 | 419 |
| Total current assets | 83 | 151 | 138 | 145 | 316 | 341 | 243 | 356 | 592 |
| Property, plant and equipment, net | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 3 |
| Marketable securities, non-current | 10 | 11 | - | - | 2 | - | - | - | 140 |
| Total non-current assets | 11 | 13 | 2 | 10 | 9 | 7 | 5 | 2 | 153 |
| Total assets | 94 | 164 | 139 | 155 | 324 | 348 | 248 | 358 | 745 |
| Accounts payable | 1 | 1 | 6 | 3 | 3 | 2 | 4 | 1 | 2 |
| Total current liabilities | 6 | 43 | 26 | 35 | 40 | 44 | 31 | 21 | 47 |
| Long-term debt, non-current | - | - | - | 10 | - | - | - | - | - |
| Total non-current liabilities | - | 1 | 1 | 40 | 5 | 4 | 1 | - | 22 |
| Total liabilities | 6 | 43 | 27 | 75 | 45 | 48 | 32 | 21 | 69 |
| Common stock and paid-in capital | - | - | - | - | - | - | - | 0 | 0 |
| Retained earnings | -65 | -102 | -140 | -218 | -284 | -409 | -537 | -616 | -340 |
| Stockholders' equity | 88 | 121 | 113 | 80 | 280 | 300 | 216 | 337 | 675 |
| Total debt | - | - | - | 10 | - | - | - | - | - |
| Net debt | - | - | - | -124 | - | - | - | - | - |
| D/E ratio (%) | - | - | - | 12.2 | - | - | - | - | - |